OR WAIT null SECS
August 06, 2020
The expansion will involve using the facilities’ existing central utilities and labs to supplement its small-scale and large-scale assets.
August 04, 2020
PPD announced it will provide drug development services to advance Pfizer’s portfolio.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.
The company’s SLIM technology has been a part of the company’s accelerated growth by offering enhanced R&D analytics.
The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.
July 31, 2020
The new manufacturing company has been launched under the Defense Production Act to produce APIs in the US.
The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.
July 30, 2020
Vico Therapeutics has raised $31 million (€27 million) in a Series A financing round, which the company will use to further advance its Antisense OligoNucleotides lead platform.
PCI Pharma has announced the creation of a new clinical center of excellence in Western Europe at its site in Berlin, Germany.
Avacta Group has expanded its partnership with Daewoong Pharmaceutical to include Affimer molecules that target viruses, such as coronavirus.